Ab Science Sa Stock Performance
| ABSCF Stock | USD 1.45 0.18 14.17% |
On a scale of 0 to 100, AB Science holds a performance score of 10. The firm owns a Beta (Systematic Risk) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, AB Science's returns are expected to increase less than the market. However, during the bear market, the loss of holding AB Science is expected to be smaller as well. Please check AB Science's treynor ratio, day typical price, and the relationship between the information ratio and daily balance of power , to make a quick decision on whether AB Science's current price history will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in AB Science SA are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, AB Science reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 20.7 M | |
| Total Cashflows From Investing Activities | -590 K | |
| Free Cash Flow | -17.7 M |
ABSCF |
AB Science Relative Risk vs. Return Landscape
If you would invest 126.00 in AB Science SA on September 28, 2025 and sell it today you would earn a total of 19.00 from holding AB Science SA or generate 15.08% return on investment over 90 days. AB Science SA is currently producing 0.2339% returns and takes up 1.7729% volatility of returns over 90 trading days. Put another way, 15% of traded pink sheets are less volatile than ABSCF, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
AB Science Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AB Science's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as AB Science SA, and traders can use it to determine the average amount a AB Science's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1319
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ABSCF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average AB Science is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AB Science by adding it to a well-diversified portfolio.
AB Science Fundamentals Growth
ABSCF Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of AB Science, and AB Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ABSCF Pink Sheet performance.
| Return On Asset | -0.43 | |||
| Operating Margin | (12.22) % | |||
| Current Valuation | 449.58 M | |||
| Shares Outstanding | 46.86 M | |||
| Price To Earning | (13.81) X | |||
| Price To Sales | 328.86 X | |||
| Revenue | 1.61 M | |||
| EBITDA | (11.41 M) | |||
| Cash And Equivalents | 7.64 M | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 6.69 M | |||
| Debt To Equity | 102.90 % | |||
| Book Value Per Share | (0.63) X | |||
| Cash Flow From Operations | (17.18 M) | |||
| Earnings Per Share | (0.32) X | |||
| Total Asset | 21.27 M | |||
| Retained Earnings | (144 M) | |||
| Current Asset | 32 M | |||
| Current Liabilities | 19 M | |||
About AB Science Performance
By analyzing AB Science's fundamental ratios, stakeholders can gain valuable insights into AB Science's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AB Science has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AB Science has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France. Ab Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 100 people.Things to note about AB Science SA performance evaluation
Checking the ongoing alerts about AB Science for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for AB Science SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AB Science SA may become a speculative penny stock | |
| AB Science SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| AB Science SA has accumulated 6.69 M in total debt with debt to equity ratio (D/E) of 102.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AB Science SA has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AB Science until it has trouble settling it off, either with new capital or with free cash flow. So, AB Science's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AB Science SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ABSCF to invest in growth at high rates of return. When we think about AB Science's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.61 M. Net Loss for the year was (14.46 M) with profit before overhead, payroll, taxes, and interest of 1.5 M. | |
| AB Science SA has accumulated about 7.64 M in cash with (17.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16. | |
| Roughly 41.0% of AB Science shares are held by company insiders |
- Analyzing AB Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AB Science's stock is overvalued or undervalued compared to its peers.
- Examining AB Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AB Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AB Science's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AB Science's pink sheet. These opinions can provide insight into AB Science's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ABSCF Pink Sheet analysis
When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |